Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1][2] It was developed for the detection of colorectal tumors, but has never been marketed.[3]
The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[4]
Non-renewal of the marketing authorisation in the European Union
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.
This nuclear medicine article is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 3.22.248.162